GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the UNITY ® Vitreoretinal Cataract System (VCS) and UNITY ® ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — Alcon announced the launch of a new Web site that it is sponsoring for the education of patients ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced key data that will be presented at this year’s American ...
Alcon’s Symposia on new generation phaco and vitrectomy system will discuss new data on anterior chamber stability during cataract surgery performed at more physiologic IOP AHMEDABAD, India, August 19 ...
Please provide your email address to receive an email when new articles are posted on . For Cataract Awareness Month in June, Alcon launched “See What You’re Missing,” a digital campaign designed to ...
Novartis' Alcon will introduce its recently CE-marked Clareon intraocular lens with an automated delivery system at the European Society of Cataract and Refractive Surgeons Congress next week. The ...
Novartis’ eye care division Alcon has set a goal to develop a digital platform for streamlining cataract surgery, in collaboration with Philips. The planned SMART Suite aims to link diagnostic and ...
Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...
“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...
Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results